The "HER2-PI3K/Akt-FASN Axis" Regulated Malignant Phenotype of Colorectal Cancer Cells

被引:18
|
作者
Li, Nan [1 ]
Bu, Xiaodong [1 ,2 ]
Wu, Peng [2 ,3 ]
Wu, Pingping
Huang, Peilin [1 ,2 ,4 ]
机构
[1] Southeast Univ, Sch Med, Dept Internal Med, Nanjing 210009, Jiangsu, Peoples R China
[2] Southeast Univ, Sch Med, Dept Pathol, Nanjing 210009, Jiangsu, Peoples R China
[3] Tumor Hosp Jiangsu Prov, Dept Internal Med, Nanjing, Jiangsu, Peoples R China
[4] Southeast Univ, Affiliated Hosp 2, Dept Internal Med, Nanjing 210009, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
HER2; The PI3K/Akt signaling pathway; FASN; Proliferation; Migration; Apoptosis; Caco-2; cells; FATTY-ACID SYNTHASE; BREAST-CANCER; EXPRESSION; INHIBITOR; RECEPTORS; GROWTH; HER2; OVEREXPRESSION; ACTIVATION; HER-2/NEU;
D O I
10.1007/s11745-011-3649-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent evidence suggests that HER2 (ErbB2; Her-2/neu) and the related PI3K/Akt signaling pathway substantially affect the malignant phenotype of colorectal cancer cells. Moreover, fatty acid synthase (FASN), which mediates de-novo fatty acid synthesis, is crucially important in the carcinogenesis process of a variety of cancers, including colorectal cancer. The purpose of this study was to investigate the malignant phenotype regulation of colorectal cancer cells via the "HER2-PI3K/Akt-FASN axis". Caco-2 cells with high expression of HER2 and FASN and high transfection efficiency were selected for functional characterization. The cells were transfected with either HER2-specific RNAi plasmid or negative control RNAi plasmid, followed by Q-RT-PCR and western blot assays to examine expression of HER2, PI3K, Akt, and FASN. MTT and colony-formation assays were used to assess proliferation. Migration was investigated by use of the transwell assay, and apoptosis and cell cycle were assayed by use of flow cytometry. Expression of HER2, PI3K, Akt, and FASN were downregulated when HER2 was silenced. Proliferation decreased after downregulation of HER2, which was consistent with increased apoptosis. Migration of HER2-silenced cells was also impaired. Loss of HER2 inhibits the activity of the "HER2-PI3K/Akt-FASN axis" of Caco-2 cells, and reduced activity of this axis alters the malignant behavior of Caco-2 cells.
引用
收藏
页码:403 / 411
页数:9
相关论文
共 50 条
  • [1] Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro
    Long, Xin-Hua
    Zhang, Guo-Mei
    Peng, Ai-Fen
    Luo, Qing-Feng
    Zhang, Lin
    Wen, Hui-Cai
    Zhou, Rong-Ping
    Gao, Song
    Zhou, Yang
    Liu, Zhi-Li
    ONCOLOGY REPORTS, 2014, 31 (01) : 328 - 334
  • [2] Loss of fatty acid synthase inhibits the "HER2-PI3K/Akt axis" activity and malignant phenotype of Caco-2 cells
    Li, Nan
    Lu, Heng
    Chen, Chunyan
    Bu, Xiaodong
    Huang, Peilin
    LIPIDS IN HEALTH AND DISEASE, 2013, 12
  • [3] Fatty Acid Synthase Regulates Proliferation and Migration of Colorectal Cancer Cells Via HER2-PI3K/Akt Signaling Pathway
    Li, Nan
    Bu, Xiaodong
    Tian, Xiaoqiang
    Wu, Peng
    Yang, Lin
    Huang, Peilin
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2012, 64 (06): : 864 - 870
  • [4] Loss of fatty acid synthase inhibits the “HER2-PI3K/Akt axis” activity and malignant phenotype of Caco-2 cells
    Nan Li
    Heng Lu
    Chunyan Chen
    Xiaodong Bu
    Peilin Huang
    Lipids in Health and Disease, 12
  • [5] Anticancer Effects of a Korean Herbal Medicine Formula (H9) via AMPK and HER2-PI3K/Akt Signaling in Breast Cancer Cells
    Lee, Ju-Hee
    Son, Young Hoon
    Kwon, Young-Won
    Park, Sung Yun
    Koo, Byung-Soo
    Jung, Seung Hyun
    PHYTOTHERAPY RESEARCH, 2017, 31 (11) : 1765 - 1775
  • [6] PI3K/Akt and GSK-3β prevents in a differential fashion the malignant phenotype of colorectal cancer cells
    de Araujo, Wallace Martins
    Branco Vidal, Flavia Castello
    de Souza, Waldemir Fernandes
    Madureira de Freitas Junior, Julio Cesar
    de Souza, Wanderley
    Morgado-Diaz, Jose Andres
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (11) : 1773 - 1782
  • [7] Growth Suppression of HER2-Overexpressing Breast Cancer Cells by Berberine via Modulation of the HER2/PI3K/Akt Signaling Pathway
    Kuo, Han-Peng
    Chuang, Tzu-Chao
    Yeh, Ming-Han
    Hsu, Shih-Chung
    Way, Tzong-Der
    Chen, Po-Yuan
    Wang, Shan-Shue
    Chang, Yung-Hsien
    Kao, Ming-Ching
    Liu, Jah-Yao
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2011, 59 (15) : 8216 - 8224
  • [8] Down-regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP-1c axis
    Tao, Ting
    Su, Qiongli
    Xu, Simeng
    Deng, Jun
    Zhou, Sichun
    Zhuang, Yu
    Huang, Yanjun
    He, Caimei
    He, Shanping
    Peng, Mei
    Hocher, Berthold
    Yang, Xiaoping
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (03) : 3088 - 3104
  • [9] Optimal Targeting of HER2-PI3K Signaling in Breast Cancer: Mechanistic Insights and Clinical Implications
    Rexer, Brent N.
    Arteaga, Carlos L.
    CANCER RESEARCH, 2013, 73 (13) : 3817 - 3820
  • [10] Cancer therapy targeting the HER2-PI3K pathway: potential impact on the heart
    Klement, Giannoula L.
    Goukassian, David
    Hlatky, Lynn
    Carrozza, Joseph
    Morgan, James P.
    Yan, Xinhua
    FRONTIERS IN PHARMACOLOGY, 2012, 3